Literature DB >> 31022516

A comparative study of the epiligament of the medial collateral and the anterior cruciate ligament in the human knee. Immunohistochemical analysis of collagen type I and V and procollagen type III.

Georgi P Georgiev1, Georgi Kotov2, Alexandar Iliev3, Svetoslav Slavchev4, Wladimir Ovtscharoff2, Boycho Landzhov2.   

Abstract

BACKGROUND: Recent reports in rat models have shown that fibroblasts in the epiligament, an enveloping tissue of the ligament, are not static cells and play an important role during the early ligament healing of isolated grade III injury of the collateral ligaments of the knee. Fibroblasts produce collagen types I, III and V and infiltrate within the ligament body via the endoligament. In addition, similarities have been reported between the structure of the epiligament of the medial collateral ligament and anterior cruciate ligament of the knee in rat and in human. In line with the ascribed role of the epiligament tissue and the synthesis of these collagens and their role in ligament healing, the aim of this study was to determine their presence in the normal epiligament of the aforementioned ligaments in humans, to compare their differential expression and to present a novel hypothesis about the failure of healing of the anterior cruciate ligament in contrast to the medial collateral ligament.
MATERIALS AND METHODS: We used samples from the mid-substance of the medial collateral and the anterior cruciate ligament of the knee joint, acquired from 12 fresh knee joints. Routine histological analysis was performed through hematoxylin and eosin stain, Mallory's trichrome stain and Van Gieson's stain. The immunohistochemical analysis was conducted using monoclonal antibodies against collagen type I and V and procollagen type III. The number of cells in the epiligament, endoligament and the ligament tissue was assessed quantitatively through a computerized system for image analysis NIS-Elements Advanced Research and Statistica software.
RESULTS: Our observations revealed certain differences in the morphology of the epiligament, as well as variations in the expression of the investigated molecules. Expression of collagen type I was mostly low-positive (1+) in the epiligament and positive (2+) in the ligament tissue of both ligaments. Expression of procollagen type III was mostly positive (2+) in the epiligament and ligament tissue of the medial collateral ligament, low-positive (1+) in the epiligament and negative (0) in ligament tissue of the anterior cruciate ligament. Expression of collagen type V was predominantly low-positive (1+) in the epiligament and negative (0) in the ligament tissue of both ligaments. The immunoreactivity for all three molecules was always higher in the epiligament of the medial collateral ligament than that of the anterior cruciate ligament.
CONCLUSIONS: The results of our study illustrate for the first time that fibroblasts in the human epiligament are indeed responsible for the synthesis of the main types of collagen participating in the early ligament healing, thus corresponding to previous data of the medial collateral ligament healing in animal models. The differences between the epiligament of the investigated ligaments could add a novel explanation for the failed anterior cruciate ligament healing.
Copyright © 2019 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Anterior cruciate ligament (ACL); Collagen type I; Collagen type V; Epiligament; Human knee; Medial collateral ligament (MCL); Procollagen type III

Mesh:

Substances:

Year:  2019        PMID: 31022516     DOI: 10.1016/j.aanat.2019.04.002

Source DB:  PubMed          Journal:  Ann Anat        ISSN: 0940-9602            Impact factor:   2.698


  8 in total

1.  ACL repair for athletes?

Authors:  Anshu Shekhar; Anoop Pilar; K M Ponnanna; Sachin Tapasvi
Journal:  J Orthop       Date:  2022-04-07

Review 2.  Intraarticular Ligament Degeneration Is Interrelated with Cartilage and Bone Destruction in Osteoarthritis.

Authors:  Gundula Schulze-Tanzil
Journal:  Cells       Date:  2019-08-27       Impact factor: 6.600

Review 3.  The Epiligament: Structure, Postnatal Development and Role in Ligament Healing.

Authors:  Nikola Stamenov; Paoleta Yordanova; Dimo Dimitrov; Militsa Telbiyska; Mark Stefanov
Journal:  Cureus       Date:  2019-06-05

4.  The acromioclavicular ligament shows an early and dynamic healing response following acute traumatic rupture.

Authors:  Dirk Maier; Lars-Rene Tuecking; Anke Bernstein; Gernot Lang; Ferdinand Christian Wagner; Martin Jaeger; Peter Ogon; Norbert Paul Südkamp; Kaywan Izadpanah
Journal:  BMC Musculoskelet Disord       Date:  2020-09-04       Impact factor: 2.362

Review 5.  The novel epiligament theory: differences in healing failure between the medial collateral and anterior cruciate ligaments.

Authors:  Georgi P Georgiev; Manasi Telang; Boycho Landzhov; Łukasz Olewnik; Svetoslav A Slavchev; Robert F LaPrade; Kacper Ruzik; R Shane Tubbs
Journal:  J Exp Orthop       Date:  2022-01-14

6.  Differences in the expression profiles of lncRNAs and mRNAs in partially injured anterior cruciate ligament and medial collateral ligament of rabbits.

Authors:  Huining Gu; Siyuan Chen; Mingzheng Zhang; Yu Wen; Bin Li
Journal:  PeerJ       Date:  2022-01-12       Impact factor: 2.984

7.  Influence of type I collagen polymorphisms and risk of anterior cruciate ligament rupture in athletes: a case-control study.

Authors:  Jamila Alessandra Perini; Lucas Rafael Lopes; João Antonio Matheus Guimarães; Rodrigo Araújo Goes; Luiz Fernando Alves Pereira; Camili Gomes Pereira; Marcelo Mandarino; Alfredo Marques Villardi; Eduardo Branco de Sousa; Victor Rodrigues Amaral Cossich
Journal:  BMC Musculoskelet Disord       Date:  2022-02-16       Impact factor: 2.362

8.  Ultrastructural and Physicochemical Characterization of a Non-Crosslinked Type 1 Bovine Derived Collagen Membrane.

Authors:  Igor da Silva Brum; Carlos Nelson Elias; Ana Lucia Rosa Nascimento; Cherley Borba Vieira de Andrade; Ronaldo Sergio de Biasi; Jorge José de Carvalho
Journal:  Polymers (Basel)       Date:  2021-11-26       Impact factor: 4.329

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.